Behavioral, Hormonal, Inflammatory, and Metabolic Effects Associated with FGF21-Pathway Activation in an ALS Mouse Model
Delaye, J. B., Lanznaster, D., Veyrat-Durebex, C., Fontaine, A., Bacle, G., Lefevre, A., Hergesheimer, R., Lecron, J. C., Vourcâh, P., Andres, C. R., Maillot, F., Corcia, P., Emond, P., Blasco, H.Journal:
Neurotherapeutics
DOI:
10.1007/s13311-020-00933-3
Date:
October, 2020
File:
PDF, 1.86 MB
2020